Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q2 2014 · 10-Q
Revenue$544.35K$544.35K+31.0% vs Q2 2013 Net Income-$835.84K-$835.84KN/M vs Q2 2013 EPS Diluted-$0.01-$0.01— vs Q2 2013 Gross Profit$274,904+47.8% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$408,762— Margins · derivedGross margin50.5%+5.8 pt vs Q2 2013
Net margin-153.5%−145.8 pt vs Q2 2013
ended Jun 30, 2014 · filed Aug 14, 2014 · 45 d after period end